Tomorrow.

Our thoughts and ideas on what's next.

visit levick.com

Levick Blog

Tomorrow.

close

Connect.

We're on.
And we're available.

DC

1900 M Street NW
Washington, DC 20036
P 202.973.1300

NY

122 East 42nd Street
New York, NY 10168
P 917.612.8419

CHICAGO

70 West Madison Street
Chicago, IL 60602
P 312.214.2300

SF

535 Mission Street
San Francisco, CA 94105
P 415. 433.0100

LEVICK

September 07, 2016

Richard Levick in WSJ

Richard Levick was recently quoted in the Wall Street Journal on Mylan’s handling of the EpiPen crisis:

“It’s not good when a corporate crisis gets its own hashtag and thousands of people begin using it. It’s even worse when that hashtag ends in ‘gate.’ Yet Mylan’s handling of its EpiPen pricing issue–#Epigate as it was tagged by one parent/activist–is hardly scandalous. In truth, once it became a news story three days after #Epigate was coined, Mylan deserves reasonably high marks for its response.  Its messaging and strategy were solid. It offered a discounted purchasing plan. It took the dramatic step of developing a generic alternative to make EpiPen more affordable. Its chief executive assumed public responsibility and made herself accessible to the media.”

 

Comments: 0
Categories: This Week
Tags:
Posted by: LEVICK

No comments